Confidence in
Simulation & AI
We create software that accelerates evidence-based decision making, supported by transparent modelling, simulation and AI.
We help our global clients and partners to communicate, collaborate, understand and retain IP.
Your Challenges.
Our Offerings.
Simomics Reason
Represent complex arguments, model design and rationale in a transparent and simple way with our goal structuring notation (GSN) diagramming tool.
Virtual Labs
Explore and utilise data and in-silico models to inform and accelerate decision making in a bespoke cloud based virtual laboratory.
Maximise
Integrate data from multiple sources and owners with machine learning to classify and protect sensitive data.
Bespoke Development
Bespoke model and software optimisation projects and cloud based solutions utilising Simomics novel technology.
Consultancy
Hands on support and consultancy for modelling, simulation and development activities from the Simomics team.
About Simomics.
Based in York since 2014, Simomics is a software company passionate about developing software to enable evidence based decision-making, promoting environmental stewardship and the 3Rs (Replacement, Refinement & Reduction of animal testing).
We develop technologies to explore, communicate and maximise the value from computer based (in-silico) models, simulations and AI to accelerate and de-risk R&D.
Combining world leading expertise in life science, software engineering and data science, we work with global clients and partners in the pharmaceutical, agrochemical, personal care and environmental industries.
Has been awarded in research grant funding to Simomics.
Citations have been made from our academic founders’ publications in the fields of computation & immunology.
We help the biggest and brightest have confidence in decisions,
and the data, models and AI behind them.
We are developing the digital assessment system at the heart of the PREMIER IMI2 project for the prioritization and risk evaluation of Active Pharmaceutical Ingredients in the environment, in partnership with AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Novartis, Sanofi, Eli Lilly, Merck and others.
A world-leading personal care company has been using our Reason software since 2016 to assist with their toxicology risk assessments. We continue to be engaged to explore integration opportunities with their environmental risk assessment work.
We are working with one of the world’s largest biotech companies to re-implement a complex mathematical model for the trafficking of CAR T-cells, converting C and Python code into MATLAB. Our Simomics Evidence technology makes the code more accessible and reusable, exposing the provenance of data, evidence and assumptions.